Login / Signup
Letter: overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it!
Daniel R Van Langenberg
Abhinav Vasudevan
Published in:
Alimentary pharmacology & therapeutics (2019)
Keyphrases
</>
ulcerative colitis
adverse drug
drug induced
patients with inflammatory bowel disease